Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 Next >
3 COVID-19 Pill Stocks to Watch
Tickers AVIR MRK PFE RHHBY
Tags Market News MRK RHHBY
From Motley Fool
Why Relay Therapeutics Is Up 30% This Week
Tickers RHHBY RLAY
Tags RHHBY Market News RLAY
From Motley Fool
2 Penny Stocks That Could Soar Soon
Tickers AZN BGNE LPTX PIRS
Tags PIRS SGEN BGNE
From Motley Fool
This Company Revolutionizes What Matters for Hospitals, Big Pharma and Health Insurers
Tickers ABBV BMY GILD JNJ
Tags General JNJ GILD
From Benzinga
Is AstraZeneca Set to Soar With an Advanced Breast Cancer Treatment?
Tickers AZN RHHBY
Tags Market News RHHBY AZN
From Motley Fool
The Daily Biotech Pulse: Moderna Awaits Adcom Ruling On COVID-19 Booster Shot; Teligent Files For Chapter 11; CFO Transitions at Catalyst Biosciences, CRISPR; Lucid Diagnostics Debuts
Tickers CBIO CRSP FBIO IPOS
Tags CRSP LUCD Guidance
From Benzinga
Never Mind Ginkgo Bioworks' Drama -- This Synthetic Biology Stock Is Still a Buy
Tickers AMRS DNA RHHBY TGT
Tags AMRS RHHBY DNA
From Motley Fool
3 COVID Stocks That Can Turn $1,000 Into $10,000
Tickers AVIR DOCS FB ILMN
Tags TDOC TXG FB
From Motley Fool
Sarepta's Duchenne Gene Therapy Shows Sustained Functional Improvements
Tickers RHHBY SRPT
Tags Market News Movers News
From Benzinga
4 Key Things Investors Should Know About Pfizer's Experimental COVID-19 Pill
Tickers AVIR MRK PFE RHHBY
Tags RHHBY MRK Market News
From Motley Fool
Roche's Alzheimer's Candidate Secures FDA Breakthrough Designation
Tickers RHHBF RHHBY RHHVF
Tags RHHBF Trading Ideas News
From Benzinga
Can This Duo Outperform Merck and Ridgeback Biotherapeutics' COVID Treatment?
Tickers AVIR MRK MRNA NVAX
Tags NVAX Market News RHHBY
From Motley Fool
Merck's Oral COVID-19 Treatment Could Be Game-Changer: BofA Analyst
Tickers BNTX JNJ MRK MRNA
Tags Geoff Meacham Market News BNTX
From Benzinga
Moderna Is Down 12%. Is It Time to Buy?
Tickers MRK MRNA RHHBY
Tags Market News MRNA RHHBY
From Motley Fool
Why Novavax Stock Plunged in September
Tickers AVIR BNTX MRNA NVAX
Tags Market News MRNA BNTX
From Motley Fool
Which COVID-19 Pill Stock Is the Best Buy?
Tickers AVIR BNTX MRK PFE
Tags AVIR PFE MRK
From Motley Fool
2 Best Biotech Stocks to Buy In October
Tickers AVIR IBB MRK OCGN
Tags XBI IBB OCGN
From Motley Fool
3 Stocks That Might Soar With Pills for COVID
Tickers AVIR MRK MRNA NVAX
Tags MRK PFE AVIR
From Motley Fool
Here Are the Leaders in the Race to Develop a COVID-19 Pill
Tickers AVIR MRK PFE RDHL
Tags MRK RDHL AVIR
From Motley Fool
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
Tickers ANIP AVDL BHC CALT
Tags IBB UTHR Top Stories
From Benzinga
Labcorp's At Home Collection Kit Gets EUA Nod For Combined COVID-19 and Flu Detection
Tickers LH RHHBF RHHBY RHHVF
Tags Health Care Benzinga RHHBY
From Benzinga
BioNTech Starts Dosing In Mid-Stage Colorectal Cancer Immunotherapy Trial
Tickers BNTX RHHBF RHHBY RHHVF
Tags Biotech Health Care Benzinga
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
Tickers ABBV ADMA AGTC AIM
Tags HOOK LCTX ORTX
From Benzinga
Regeneron-Roche Post Encouraging New Data For COVID-19 Antibody Cocktail
Tickers REGN RHHBF RHHBY RHHVF
Tags REGN RHHBY Benzinga
From Benzinga
3 COVID Stocks Ready to Take On the Delta Variant
Tickers BNTX GILD LLY NVAX
Tags PFE LLY NVAX
From Motley Fool
Glaxo - Vir Biotech's COVID Treatment Approved In Japan
Tickers GSK REGN RHHBF RHHBY
Tags News Market News RHHBF
From Benzinga
3 Biotech Stocks That Could Make You Filthy Rich
Tickers ADAP AMGN AZN CHGCY
Tags AMGN Market News VSTM
From Motley Fool
Acceleron In Advanced $11B Buyout Talks: Bloomberg
Tickers AMGN BMY GILD MRK
Tags News GILD Market News
From Benzinga
September Sell-Off Alert: Buy Vertex Pharmaceuticals on the Dip
Tickers CRSP NDAQ RHHBY VRTX
Tags VRTX NDAQ Market News
From Motley Fool
Roche Builds Case For Evrysdi Benefits In Younger Spinal Muscular Atrophy Patients
Tickers RHHBF RHHBY RHHVF
Tags News Market News RHHBY
From Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]